Quantitation and Localization of Matrix Metalloproteinases and Their Inhibitors in Human Carotid Endarterectomy Tissues
Authors:
- 1 October 2006
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 26 (10) , 2351-2358
Abstract
Background— Matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) play a central role in arterial wall remodeling, affecting stability of fibrous caps covering atherosclerotic plaques. The objective of this study was to determine the spatial distribution of TIMP mass and MMP mass and activity of carotid endarterectomy (CEA) tissues and relate it to the distribution of atherosclerotic lesions. Methods and Results— Fresh CEA tissues were imaged by multicontrast MRI to generate 3D reconstructions. Tissue segments were cut transversely from the common, bifurcation, internal, and external regions. Segments were subjected to total protein extractions and analyzed by ELISA for MMP-2 and -9 and TIMP-1 and -2 mass and by zymography for gelatinase activity. Segments at or near the bifurcation with highly calcified lesions contained higher MMP levels and activity than segments distant from the bifurcation; highly fibrotic or necrotic plaque contained lower MMP levels and activity and higher TIMP levels. Fatty streak, fibroatheroma with hemorrhage and calcification, and fully occluded lesions were enriched in MMP-2, MMP-9, and TIMP-1 and TIMP-2, respectively. Conclusion— The spatial distribution of MMPs and TIMPs in carotid atherosclerotic lesions is highly heterogeneous, reflecting lesion location, size, and composition. This study provides the first semi-quantitative maps of differential distribution of MMPs and TIMPs over atherosclerotic plaques.Keywords
This publication has 27 references indexed in Scilit:
- Quantification of Calcification in Atherosclerotic LesionsArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Metalloproteinase-2 and -9 in Giant Cell ArteritisCirculation, 2005
- Metalloproteinases and their inhibitors are markers of plaque instabilitySurgery, 2005
- Zymographic Techniques for the Analysis of Matrix Metalloproteinases and their InhibitorsBioTechniques, 2005
- Relationship of Matrix Metalloproteinases and Macrophages to Embolization During Endoluminal Carotid InterventionsJournal of Endovascular Therapy, 2004
- Structure of Human Pro-Matrix Metalloproteinase-2: Activation Mechanism RevealedScience, 1999
- Increased mRNA expression of metalloproteinase-9 in peripheral blood monocytes from patients with immunoglobulin a nephropathyAmerican Journal of Kidney Diseases, 1996
- The extracellular matrix and atherosclerosisCurrent Opinion in Lipidology, 1995
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993
- The N-terminal domain of tissue inhibitor of metalloproteinases retains metalloproteinase inhibitory activityBiochemistry, 1991